• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Spyre Therapeutics, Inc. - Common Stock (NQ: SYRE )

    35.01 -0.81 (-2.28%)
    Streaming Delayed Price Updated: 11:41 AM EST, Nov 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Spyre Therapeutics, Inc. - Common Stock

    SYRE Stock Earnings: Spyre Therapeutics Beats EPS for Q2 2024
    SYRE stock results show that Spyre Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    SYRE Stock Earnings: Spyre Therapeutics Misses EPS for Q1 2024
    SYRE stock results show that Spyre Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
    U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.